IMAX Corporation (IMAX) — closed signal from November 28, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on February 26, 2026.
Predicted vs. what happened
What happened
Reached its target in 90 days.
The thesis — published November 28, 2025
This is a short-term trade for about three months. Big holiday movies like Zootopia 2 and Wicked could bring more people to IMAX and lift ticket sales near term. But the company's core business is weak and some analysts recently recommended selling, so only risk a small amount and use strict stops.
Primary drivers
- Holiday films may bring more viewers and higher ticket sales.
- Recent price action shows strong buying interest from traders.
- Market excitement is much higher than the company's results.
- A recent sell recommendation highlights sales and value risk.
How it played out
IMAX: target reached in 90 days
Lyra published IMAX at $37.29 on 2025-11-28 as a short-term trade for about three months. The thesis expected 13% growth and pointed to holiday films bringing more viewers and higher ticket sales. It also pointed to strong buying interest from traders, while noting weak core business, high market excitement versus results, and a recent sell recommendation.
Inside the window, IMAX reached a peak of $42.46 on 2026-02-26, above the $42.14 target. The peak gain was 13.9%, and the target was reached in 90 days. The stock ended the window at $41.77. The thesis played out.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.